Ensign Group/$ENSG
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Ensign Group
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
Ticker
$ENSG
Sector
Primary listing
Employees
39,300
Headquarters
Website
Ensign Group Metrics
BasicAdvanced
$10B
32.25
$5.52
0.94
$0.25
0.14%
Price and volume
Market cap
$10B
Beta
0.94
52-week high
$179.27
52-week low
$118.73
Average daily volume
354K
Dividend rate
$0.25
Financial strength
Current ratio
1.412
Quick ratio
1.319
Long term debt to equity
95.587
Total debt to equity
100.93
Dividend payout ratio (TTM)
4.35%
Interest coverage (TTM)
47.61%
Profitability
EBITDA (TTM)
490.185
Gross margin (TTM)
16.48%
Net profit margin (TTM)
6.99%
Operating margin (TTM)
8.61%
Effective tax rate (TTM)
23.68%
Revenue per employee (TTM)
$120,000
Management effectiveness
Return on assets (TTM)
5.30%
Return on equity (TTM)
17.54%
Valuation
Price to earnings (TTM)
32.254
Price to revenue (TTM)
2.199
Price to book
5.05
Price to tangible book (TTM)
5.33
Price to free cash flow (TTM)
73.765
Free cash flow yield (TTM)
1.36%
Free cash flow per share (TTM)
2.413
Dividend yield (TTM)
0.14%
Forward dividend yield
0.14%
Growth
Revenue change (TTM)
16.31%
Earnings per share change (TTM)
41.66%
3-year revenue growth (CAGR)
18.02%
10-year revenue growth (CAGR)
14.85%
3-year earnings per share growth (CAGR)
15.41%
10-year earnings per share growth (CAGR)
18.69%
3-year dividend per share growth (CAGR)
4.40%
10-year dividend per share growth (CAGR)
5.31%
What the Analysts think about Ensign Group
Analyst ratings (Buy, Hold, Sell) for Ensign Group stock.
Bulls say / Bears say
Adjusted Q2 2025 EPS rose 20.5% year-over-year to $1.59, beating the analyst consensus of $1.55 and demonstrating strong organic and acquisition-driven growth (Nasdaq).
Same-store occupancy reached a record 82.1% (+2.0 percentage points) and transitioning facilities hit 84.0% (+4.6 points) in Q2 2025, underscoring Ensign’s operational excellence and strong patient demand (GlobeNewswire).
Ensign maintained a conservative net debt to adjusted EBITDAR ratio of 1.97x with $364 million in cash, and returned capital via $20 million of share repurchases and its 22nd consecutive annual dividend increase, supporting financial flexibility (Nasdaq).
Total operating expenses in Q2 2025 rose 12.7% year-over-year due to higher costs of services, general and administrative expenses, and rent, which could compress margins if revenue growth moderates (Nasdaq).
Approximately 70% of Ensign’s service revenue is derived from Medicare and Medicaid, exposing the company to significant reimbursement risk; proposed CMS reforms under the SNF-VBP program beginning in 2026 may reduce payment rates or impose penalties (SEC 10-Q).
Cash and cash equivalents fell 21.7% year-over-year to $364 million at the end of Q2 2025, reducing Ensign’s liquidity buffer and potentially constraining its capacity for acquisitions or capital expenditures (Nasdaq).
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.
Ensign Group Financial Performance
Revenues and expenses
Ensign Group Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Ensign Group stock?
Ensign Group (ENSG) has a market cap of $10B as of October 15, 2025.
What is the P/E ratio for Ensign Group stock?
The price to earnings (P/E) ratio for Ensign Group (ENSG) stock is 32.25 as of October 15, 2025.
Does Ensign Group stock pay dividends?
Yes, the Ensign Group (ENSG) stock pays dividends to shareholders. As of October 15, 2025, the dividend rate is $0.2475 and the yield is 0.14%. Ensign Group has a payout ratio of 4.35% on a trailing twelve-month basis.
When is the next Ensign Group dividend payment date?
The next Ensign Group (ENSG) dividend payment is scheduled for October 31, 2025.
What is the beta indicator for Ensign Group?
Ensign Group (ENSG) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.